Autopsy report · NCT01080768
Assessment of Aliskiren/Amlodipine and Amlodipine on Ankle Foot Volume (AFV) in Patients With Hypertension
Cause of deathOther
“Publication of data from a similar study made the current study redundant.”
Life of this trial
- Ran for about 9 months before it stopped.
- 31 participants enrolled.
- Results were posted on the registry 1 year 1 month after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Novartis Pharmaceuticals
- Sponsor type
- Industry
- Conditions
- Hypertension; Ankle Edema
- Interventions
- Aliskiren/amlodipine; Amlodipine; Placebo to Aliskiren/amlodipine; Placebo to Amlodipine
- Participants
- 31
- Sites
- 9
- Countries
- Netherlands
Trials that died the same way
- Embolectomy in Acute SYlvian Thrombosis in Refractory or Ineligible Patients to ALteplase
“After results of other studies published : EASY study became lapsed” - Use of Magnetic Imaging to Asses the Efficacy of Cap Assisted Colonoscopy in Reducing Looping and Improving Patient Acceptance for the Colonoscopy Procedure
“The study was incorporated in another study.” - Refobacin Revision-3 Bone Cement Post-Market Study
“The study was discontinued upon availability of relevant data through bespoke reporting, which fulfilled the study's primary objectives” - Management of Type 2 Diabetes After Gastric Bypass Surgery
“Data were published that superseded this study.” - Gene Expression During Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Choline Magnesium Trisalicylate
“Replaced by another study”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.